The validation of anxiety rating scales in Parkinson's disease
Completed
- Conditions
- anxietyparkinson's disease1002803710002861
- Registration Number
- NL-OMON32820
- Lead Sponsor
- Academisch Ziekenhuis Maastricht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
- Idiopathic Parkinson's Disease according to the Queens Square Brain Bank criteria
- Informed consent
Exclusion Criteria
- patients with neurodegenerative disorders other than PD
- patients under 50 years of age
- dementia or severe cognitive decline, operationalised as an Mini Mental State Exam score < 23
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary study parameters are the validity and reliability of the anxiety<br /><br>rating scales used resp; the Neuropsychiatric Invertory, anxiety section, the<br /><br>Hamilton Anxiety Rating Scale. the Clinical Global Impression Scale, the Beck<br /><br>Anxiety Inventory and the Hospital Anxiety and Depression Scale.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secundary study parameters are:<br /><br>- prevalence rates of van anxiety disorders<br /><br>- atypical anxiety syndromes will be looked into by exploratory clusteranalysis<br /><br>of items on the various anxiety scales<br /><br>- anxiety states limited to 'off'periods and/or dyskinesia will be described by<br /><br>looking at score patterns across the additional questions pertaining to<br /><br>response fluctuations (see appendix protocol)</p><br>